GWAS of cataract in Puerto Ricans identifies a novel large-effect variant in ITGA6

Jingchunzi Shi, Jared O’Connell, Barry Hicks, Wei Wang, Katarzyna Bryc, Jennifer J. Brady, Vladimir Vacic, Will Freyman, Noura S. Abul‐Husn, Adam Auton, Suyash ShringarpuremedRxiv 2023 · DOI

This research paper, published by the 23andMe Research Team, describes a genome-wide association study (GWAS) that identified a rare but high-impact genetic variant linked to cataracts in the Puerto Rican population. By focusing on an underrepresented group, the researchers discovered a risk factor that had been completely missed in larger studies of European and Asian populations.

TL;DR

Researchers identified a rare coding variant in the ITGA6 gene that increases the risk of cataracts in Puerto Ricans by more than 12-fold and accelerates disease onset by nearly 14 years. The variant likely originated in North Africa and reached the Americas via historical migration, highlighting how population-specific "founder effects" can reveal critical disease biology.

What Problem Does This Paper Address?

Cataracts—the clouding of the eye's lens—are a leading cause of vision loss globally. While we know genetics play a significant role (heritability is estimated at 35-58%), most genetic research has focused on people of European or Asian descent.

Hispanic and Latino populations often show higher rates of cataracts, yet their specific genetic risk factors remain poorly understood. This "genomic gap" means that rare, high-effect variants present in specific ancestral lineages are often overlooked. This paper aims to fill that gap by performing the first large-scale GWAS specifically targeting the Puerto Rican population.

Methods

The study utilized data from over 45,000 research-consented 23andMe customers of Puerto Rican ancestry. To overcome the limitations of standard genetic arrays, the team used several sophisticated techniques:

  • Custom Imputation Panel: They sequenced the full genomes of 500 Puerto Rican individuals to create a population-specific reference. This allowed them to "fill in the blanks" for rare variants that standard tests usually miss.
  • Identity-by-Descent (IBD) Analysis: They used IBD sharing to precisely define the Puerto Rican cohort and confirm a historical "population bottleneck" (a sharp reduction in population size) occurring about 10–12 generations ago.
  • Statistical Modeling: Beyond standard case-control association, they used Cox regression to model the "time-to-cataract" and SuSiE (Sum of Single Effects) for fine-mapping to ensure the identified variant was the likely causal driver.
  • Ancestry Inference: They mapped the local ancestry of the specific chromosomal region surrounding the risk variant to trace its geographic origins.

Datasets

  • Primary Cohort: 3,060 self-reported cataract cases and 41,890 controls from the 23andMe customer base.
  • Reference Panels: gnomAD (v3.1.2), 1000 Genomes Project, HGDP/SGDP, and GTEx-v8 were used for global frequency comparisons.
  • 4GP Cohort: A "four-grandparent" cohort of over 1 million individuals used to estimate worldwide allele frequencies.

Key Insights and Ideas

  • The Power of Founder Populations: The Puerto Rican population's history of a strong bottleneck followed by rapid expansion (a founder effect) allowed a rare variant to reach a detectable frequency (0.089%) that is virtually non-existent in the rest of the world.
  • Structural Protein Disruption: The variant (rs200560853) causes a "missense" mutation, changing a Cysteine amino acid to Tryptophan (p.Cys535Trp). Cysteine is crucial for forming disulfide bonds that stabilize protein structures. By breaking this bond in the ITGA6 protein, the mutation likely destabilizes the lens fiber cells.
  • A North African Legacy: Ancestry analysis suggests the variant originated in North Africa. It likely traveled to Puerto Rico via migrants from the Canary Islands, a known historical pathway for North African and Mediterranean genetic markers into the Caribbean.
  • Biological Plausibility: ITGA6 (Integrin Alpha 6) is known to be expressed in the eye lens and is involved in cell survival and transparency. This study provides the first strong human genetic evidence linking it to age-related cataracts.

Key Results

  • Massive Effect Size: The variant carries an Odds Ratio (OR) of 12.7. For context, most variants found in GWAS have ORs between 1.1 and 1.5.
  • Earlier Onset: Carriers of the variant develop cataracts an average of 13.7 years earlier than non-carriers.
  • Increased Event Rate: Carriers have a 4.3-fold higher rate of cataract events over their lifetime.
  • Geographic Specificity: The variant is found almost exclusively in individuals with ancestry from the Americas or countries bordering the Mediterranean (e.g., Tunisia, Morocco).

Limitations and Future Work

The authors acknowledge several limitations:

  • Self-Reporting: The study relied on self-reported diagnosis and age-of-onset, which can introduce bias, though previous studies show high correlation between self-reported and clinical cataract data.
  • Replication Challenges: Because the variant is so rare outside of Puerto Rico, finding an independent cohort large enough to replicate these specific findings is difficult.
  • Incomplete Penetrance: While the risk is high, 65% of carriers in the study were still cataract-free at the time of the survey, suggesting that other genetic or environmental factors (like UV exposure or diabetes) still play a role.
  • Next Steps: The authors call for functional "wet lab" studies (in vitro or animal models) to confirm exactly how the ITGA6 mutation disrupts lens transparency.

Summary updated

Abstract

Abstract Cataract is a common cause of vision loss and affects millions of people worldwide. Genome-wide association studies (GWAS) and family studies of cataract have demonstrated a role for genetics in cataract susceptibility. However, most of these studies have been conducted in populations of European or Asian descent, leaving the genetic etiology of cataract among Hispanic/Latino (HL) populations unclear. Here we perform the first GWAS of cataract in a Puerto Rican population of research participants derived from the customer base of 23andMe, Inc. In our analysis with 3,060 self-reported cases and 41,890 controls, we found a novel association of large effect size with a rare coding variant in the ITGA6 gene (rs200560853, p-value=2.9×10 −12 , OR=12.7, 95% CI=[6.5, 24.7]). ITGA6 is part of the integrin alpha chain in the laminin receptor subfamily, and likely contributes to eye lens homeostasis, transparency, and cell survival. We found that this coding variant is associated with a 13.7 year earlier disease onset on average, as well as a 4.3-fold higher rate of cataract events in the Puerto Rican population. The variant has a minor allele frequency (MAF) of 0.089% in Puerto Rico and is extremely rare elsewhere in the world. Population genetic analyses showed that the variant is only found in individuals with ancestry from the Americas and countries bordering the Mediterranean Sea, suggesting a North African origin. Our discovery identifies a novel genetic risk factor for cataract in Puerto Ricans and highlights the importance of including underrepresented populations in genomics research to improve our understanding of disease in all populations.
BibTeX
@misc{shi2023gwas,
  author = {Jingchunzi Shi and Jared O’Connell and Barry Hicks and Wei Wang and Katarzyna Bryc and Jennifer J. Brady and Vladimir Vacic and Will Freyman and Noura S. Abul‐Husn and Adam Auton and Suyash Shringarpure},
  title = {{GWAS of cataract in Puerto Ricans identifies a novel large-effect variant in ITGA6}},
  year = {2023},
  doi = {10.1101/2023.07.25.23293173},
  howpublished = {medRxiv},
}
Figure